Gilead raises $4B in note deal

Gilead Sciences Inc. (NASDAQ:GILD) raised $4 billion through the sale of senior unsecured notes underwritten by Merrill Lynch; JPMorgan; Barclays; and HSBC.

The notes consist of $500 million in 2.1% notes due 2020, $1.75 billion in 3.5% notes due 2025 and $1.75 billion in 4.5% notes due 2045. ...